cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.
about
Bidirectional cross-regulation between the endothelial nitric oxide synthase and β-catenin signalling pathwaysThe interaction between the Wnt/β-catenin signaling cascade and PKG activation in cancer.Capillary Isoelectric Focusing Immunoassay for Fat Cell Differentiation Proteomics.The cyclic GMP/protein kinase G pathway as a therapeutic target in head and neck squamous cell carcinomaHyperglycemia down-regulates cGMP-dependent protein kinase I expression in first trimester cytotrophoblast cells.The role of cGMP and its signaling pathways in kidney disease.New cGMP analogues restrain proliferation and migration of melanoma cells.Structural basis for selective inhibition of human PKG Iα by the balanol-like compound N46.
P2860
Q24301353-8A8A49E4-DFAD-4991-B74C-A8658277C2A6Q33768672-9860DEEA-B18B-45E3-9D33-3082BD63244FQ35679898-BEB904A4-8FE0-4566-A4C1-FB4B5A4D8740Q36458158-C5CCE1D7-6030-4A71-9DB7-5CA23B8D1199Q38888539-CCE87970-BF5B-4B02-A940-1074FE645BBEQ38896087-E542727B-0CD8-42B8-A8A4-0DB0087BABDAQ49723790-ECA5178A-AAED-49C3-B942-26C8EA0E6F50Q54978909-246267E9-657C-4652-A4E6-E183B85CAF2B
P2860
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.
@en
type
label
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.
@en
prefLabel
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.
@en
P2093
P2860
P356
P1433
P1476
cGMP-Dependent Protein Kinase Inhibitors in Health and Disease.
@en
P2093
Jens Schlossmann
Johannes P Huettner
Stefanie Wolfertstetter
P2860
P304
P356
10.3390/PH6020269
P577
2013-02-07T00:00:00Z